The landscape of Alzheimer’s disease (AD) research and treatment is undergoing a significant transformation, marked by the recent advent of…
Read More
Fine-Tuning Explained: Adapting Large Language Models for Specific Applications
The landscape of artificial intelligence has been fundamentally reshaped by the advent of large language models (LLMs), powerful AI systems…
Read More
Scientists Identify Specific Brain Circuit Controlling Anxiety and Social Withdrawal and Successfully Reverse Symptoms in Mice
In a landmark discovery for the field of neurobiology, researchers at the Institute for Neurosciences (IN), a joint center of…
Read More
Oxford Professor Unveils AI Software Humatch for Rapid, Gene-Specific Antibody Humanization, Revolutionizing Therapeutic Development
Oxford, UK – In a significant stride for pharmaceutical innovation, Professor Charlotte Dean, a leading figure in Structural Bioinformatics at…
Read More
McGill University Researchers Identify Specific Brain Cell Disruptions Linked to Major Depressive Disorder in Landmark Study
A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has unveiled specific cellular abnormalities in…
Read More
McGill Researchers Identify Specific Brain Cells Linked to Major Depressive Disorder Through Advanced Genomic Mapping
In a landmark study that bridges the gap between molecular genetics and clinical psychiatry, researchers at McGill University and the…
Read More
Nature-Inspired Precision: International Study Unveils Targeted Gene Therapy Delivery Using Specific Extracellular Vesicles
A groundbreaking international study, spearheaded by researchers from the University of Ottawa Faculty of Medicine in Canada, has introduced a…
Read More
McGill University Researchers Identify Specific Brain Cells Linked to Depression in Landmark Study
A groundbreaking study led by researchers at McGill University and the Douglas Research Centre has fundamentally altered the scientific understanding…
Read More
Gene Therapy Breakthrough Offers Non-Addictive Path for Chronic Pain Treatment via Brain-Specific Circuit Targeting
A groundbreaking preclinical study has identified a novel gene therapy that directly targets pain-processing regions within the brain, potentially revolutionizing…
Read More
Sanofi Secures Global Rights to Kali Therapeutics’ Promising Tri-Specific Antibody KT501 for Autoimmune Diseases in a Landmark $1.23 Billion Deal
Sanofi has entered into an exclusive global license agreement with Kali Therapeutics, a significant move that grants the pharmaceutical giant…
Read MoreYOU MAY HAVE MISSED
